Endocare completes Timm sale to UK's Plethora solutions:
This article was originally published in Clinica
Executive Summary
Endocare has closed the sale of its erectile dysfunction subsidiary, Timm Medical Technologies, to UK company Plethora Solutions. London-based Plethora, which develops drugs and devices for the urology market, agreed in January to pay Endocare $9.5m in cash and bonds for Timm (see Clinica No 1190, p 14).